All News Otsuka Holdings Co., Ltd.

Equities

4578

JP3188220002

Delayed Japan Exchange Other stock markets 01:30:39 2024-07-16 am EDT			5-day change	1st Jan Change
7,104 ^JPY	-0.39%		+0.98%	+34.39%

Jul. 10	Jefferies Adjusts Otsuka Holdings' Price Target to 8,100 Yen From 7,800 Yen, Keeps at Buy	MT
Jul. 09	Indivior shares dive on profit warning, dropping of schizophrenia drug (July 9)	RE

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jefferies Adjusts Otsuka Holdings' Price Target to 8,100 Yen From 7,800 Yen, Keeps at Buy	Jul. 10	MT
Indivior shares dive on profit warning, dropping of schizophrenia drug (July 9)	Jul. 09	RE
UK Pharmaceutical Trade Group Slams Novartis, Three Others for Breaches	Jul. 05	MT
Ex-dividend day for interim dividend	Jun. 26	FA
Otsuka and Lundbeck's PTSD Treatment Moves Forward as FDA Accepts New Drug Application	Jun. 25	MT
Lundbeck and Otsuka Announce FDA Acceptance of sNDA Filing for Brexpiprazole in Combination with Sertraline for the Treatment of Adults with Post-Traumatic Stress Disorder	Jun. 25	CI
Otsuka Holdings Co., Ltd. Provides Earnings Guidance for the Year 2026	Jun. 07	CI
Correction: Otsuka Pharmaceutical's PTSD Treatment Candidate Sees Statistically Significant Results in Two Out of Three Trials	May. 30	MT
Japanese Shares Close Lower as JGB Yields Hit 12-Year High	May. 29	MT
Otsuka Pharmaceutical's PTSD Treatment Candidate Fails to Meet Primary Endpoint in Phase 3 Trial	May. 28	MT
Jefferies Adjusts Otsuka Holdings' Price Target to 7,800 Yen From 7,400 Yen, Keeps at Buy	May. 23	MT
Otsuka Holdings' Attributable Profit Soars 26% in Fiscal Q1	May. 22	MT
Otsuka to stop development of Alzheimer's disease drug	May. 22	RE
Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the First Half of Fiscal Year Ending December 2024	May. 22	CI
Esperion Therapeutics Says Primary Endpoint Achieved in Hypercholesterolemia Treatment Phase 3 Trial; Shares Rise	May. 20	MT
Otsuka Holdings' Attributable Profit Jumps 26% in Q1	Apr. 30	MT
Otsuka Holdings Co., Ltd. Provides Dividend Guidance for the Second Quarter of 2024	Apr. 30	CI
Otsuka Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending December 31, 2024	Apr. 30	CI
Otsuka Holdings 2.32 Billion Yen Worth of Shares As Stock Compensation	Apr. 29	MT
H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy	Apr. 09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Otsuka Holdings Co., Ltd.

Equities

4578

JP3188220002

All News

Filters